Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ian J Jacobs

Showing results (31-40 of 83) with videos related to

Pageof 9
Sort By:
International Journal of Cancer|February 22, 2005
Low frequency of BRAF and CDKN2A mutations in endometrial cancerHelga B Salvesen, Rajiv Kumar, Ingunn Stefansson, et al.
International Journal of Oncology|November 18, 2004
Significance of PTEN alterations in endometrial carcinoma: a population-based study of mutations, promoter methylation and PTEN protein expressionHelga B Salvesen, Ingunn Stefansson, Ellen I Kretzschmar, et al.
International Journal of Cancer|July 18, 2009
DNA methylation analysis in liquid-based cytology for cervical cancer screeningSophia Apostolidou, Richard Hadwin, Matthew Burnell, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 19, 2008
BRCA1 and BRCA2 mutation prevalence and clinical characteristics of a population-based series of ovarian cancer cases from DenmarkMarie Soegaard, Susanne Kruger Kjaer, Mark Cox, et al.
Cancer|May 26, 2004
Loss of heterozygosity on the X chromosome is an independent prognostic factor in ovarian carcinoma: from the Danish "MALOVA" Ovarian Carcinoma StudyEstrid V S Høgdall, Andy Ryan, Susanne K Kjaer, et al.
Journal of the National Cancer Institute|October 7, 2004
A molecular genetic and statistical approach for the diagnosis of dual-site cancersDirk Brinkmann, Andy Ryan, Ayse Ayhan, et al.
BJOG : an International Journal of Obstetrics and Gynaecology|December 10, 2014
Performance of ultrasound as a second line test to serum CA125 in ovarian cancer screeningUsha Menon, Ahmed Talaat, Adam N Rosenthal, et al.
Journal of Medical Genetics|November 27, 2013
Ovarian cancer familial relative risks by tumour subtypes and by known ovarian cancer genetic susceptibility variantsSarah Jervis, Honglin Song, Andrew Lee, et al.
British Journal of Cancer|January 13, 2017
Testing breast cancer serum biomarkers for early detection and prognosis in pre-diagnosis samplesAnna Kazarian, Oleg Blyuss, Gergana Metodieva, et al.
Plos One|December 19, 2009
An epigenetic signature in peripheral blood predicts active ovarian cancerAndrew E Teschendorff, Usha Menon, Aleksandra Gentry-Maharaj, et al.
Pageof 9

Showing results (31-40 of 83) with videos related to

Sort By:
Pageof 9
International Journal of Cancer|February 22, 2005
Low frequency of BRAF and CDKN2A mutations in endometrial cancerHelga B Salvesen, Rajiv Kumar, Ingunn Stefansson, et al.
International Journal of Oncology|November 18, 2004
Significance of PTEN alterations in endometrial carcinoma: a population-based study of mutations, promoter methylation and PTEN protein expressionHelga B Salvesen, Ingunn Stefansson, Ellen I Kretzschmar, et al.
International Journal of Cancer|July 18, 2009
DNA methylation analysis in liquid-based cytology for cervical cancer screeningSophia Apostolidou, Richard Hadwin, Matthew Burnell, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 19, 2008
BRCA1 and BRCA2 mutation prevalence and clinical characteristics of a population-based series of ovarian cancer cases from DenmarkMarie Soegaard, Susanne Kruger Kjaer, Mark Cox, et al.
Cancer|May 26, 2004
Loss of heterozygosity on the X chromosome is an independent prognostic factor in ovarian carcinoma: from the Danish "MALOVA" Ovarian Carcinoma StudyEstrid V S Høgdall, Andy Ryan, Susanne K Kjaer, et al.
Journal of the National Cancer Institute|October 7, 2004
A molecular genetic and statistical approach for the diagnosis of dual-site cancersDirk Brinkmann, Andy Ryan, Ayse Ayhan, et al.
BJOG : an International Journal of Obstetrics and Gynaecology|December 10, 2014
Performance of ultrasound as a second line test to serum CA125 in ovarian cancer screeningUsha Menon, Ahmed Talaat, Adam N Rosenthal, et al.
Journal of Medical Genetics|November 27, 2013
Ovarian cancer familial relative risks by tumour subtypes and by known ovarian cancer genetic susceptibility variantsSarah Jervis, Honglin Song, Andrew Lee, et al.
British Journal of Cancer|January 13, 2017
Testing breast cancer serum biomarkers for early detection and prognosis in pre-diagnosis samplesAnna Kazarian, Oleg Blyuss, Gergana Metodieva, et al.
Plos One|December 19, 2009
An epigenetic signature in peripheral blood predicts active ovarian cancerAndrew E Teschendorff, Usha Menon, Aleksandra Gentry-Maharaj, et al.
Pageof 9